Prognostic role of CD82/KAI1 in multiple human malignant neoplasms: a meta-analysis of 31 studies

References

• ZollerMGastrointestinal tumors: metastasis and tetraspaninsZ Gastroenterol200644757358616823699
   PubMedGoogle Scholar
• YuntaMLazoPATetraspanin proteins as organisers of membrane microdomains and signalling complexesCell Signal200315655956412681443
   PubMedGoogle Scholar
• HemlerMETetraspanin functions and associated microdomainsNat Rev Mol Cell Biol200561080181116314869
   PubMed Web of Science ®Google Scholar
• YangYGSariINZiaMFLeeSRSongSJKwonHYTetraspanins: spanning from solid tumors to hematologic malignanciesExp Hematol201644532232826930362
   PubMed Web of Science ®Google Scholar
• RichardsonMMJenningsLKZhangXATetraspanins and tumor progressionClin Exp Metastasis201128326127021184145
   PubMed Web of Science ®Google Scholar
• YouJMadiganMCRoweASajinovicMRussellPJJacksonPAn inverse relationship between KAI1 expression, invasive ability, and MMP-2 expression and activity in bladder cancer cell linesUrol Oncol201230450250820864363
   PubMedGoogle Scholar
• LiuWIiizumi-GairaniMOkudaHKAI1 gene is engaged in NDRG1 gene-mediated metastasis suppression through the ATF3-NFkappaB complex in human prostate cancerJ Biol Chem201128621189491895921454613
   PubMed Web of Science ®Google Scholar
• ChristgenMChristgenHHeilCExpression of KAI1/CD82 in distant metastases from estrogen receptor-negative breast cancerCancer Sci200910091767177119549254
   PubMedGoogle Scholar
• MirantiCKControlling cell surface dynamics and signaling: how CD82/KAI1 suppresses metastasisCell Signal200921219621118822372
   PubMed Web of Science ®Google Scholar
• ZhuBZhouLYuLEvaluation of the correlation of vasculogenic mimicry, ALDH1, KAI1 and microvessel density in the prediction of metastasis and prognosis in colorectal carcinomaBMC Surg20171714728431527
   PubMedGoogle Scholar
• SinghRBhattMLSinghSPExpression levels of Tetraspanin KAI1/CD82 in breast cancers in North Indian femalesAsian Pac J Cancer Prev20161773431343627509988
   PubMedGoogle Scholar
• LuGZhouLZhangXThe expression of metastasis-associated in colon cancer-1 and KAI1 in gastric adenocarcinoma and their clinical significanceWorld J Surg Oncol201614127627793161
   PubMedGoogle Scholar
• YuLZhouLWuSClinicopathological significance of cancer stem cells marked by CD133 and KAI1/CD82 expression in laryngeal squamous cell carcinomaWorld J Surg Oncol20141211824758564
   PubMed Web of Science ®Google Scholar
• TangYChengYMartinkaMOngCJLiGPrognostic significance of KAI1/CD82 in human melanoma and its role in cell migration and invasion through the regulation of ING4Carcinogenesis2014351869524130172
   PubMedGoogle Scholar
• ShiwuWULanYWenqingSLeiZYishengTExpression and clinical significance of CD82/KAI1 and E-cadherin in non-small cell lung cancerArch Iran Med2012151170771223102249
   PubMedGoogle Scholar
• GuoJFanKXXieLIEffect and prognostic significance of the KAI1 gene in human gastric carcinomaOncol Lett20151042035204226622792
   PubMedGoogle Scholar
• LeaveyPJTimmonsCFrawleyWLombardiDAshfaqRKAI-1 expression in pediatric high-grade osteosarcomaPediatr Dev Pathol20069321922416944980
   PubMedGoogle Scholar
• HashidaHTakabayashiATokuharaTClinical significance of transmembrane 4 superfamily in colon cancerBr J Cancer200389115816712838318
   PubMedGoogle Scholar
• KwonHJMinSYParkMJExpression of CD9 and CD82 in clear cell renal cell carcinoma and its clinical significancePathol Res Pract2014210528529024553302
   PubMedGoogle Scholar
• WilliamsonPRSmithCTHuttonJLMarsonAGAggregate data meta-analysis with time-to-event outcomesStat Med200221223337335112407676
   PubMed Web of Science ®Google Scholar
• DerSimonianRLairdNMeta-analysis in clinical trials revisitedContemp Clin Trials201545Pt A13914526343745
   PubMed Web of Science ®Google Scholar
• TierneyJFStewartLAGhersiDBurdettSSydesMRPractical methods for incorporating summary time-to-event data into meta-analysisTrials200781617555582
   PubMed Web of Science ®Google Scholar
• DerSimonianRLairdNMeta-analysis in clinical trialsControl Clin Trials1986731771883802833
   PubMedGoogle Scholar
• EggerMDaveySGSchneiderMMinderCBias in meta-analysis detected by a simple, graphical testBMJ199731571096296349310563
   PubMed Web of Science ®Google Scholar
• FengJHuangCWrenJDTetraspanin CD82: a suppressor of solid tumors and a modulator of membrane heterogeneityCancer Metastasis Rev201534461963326335499
   PubMedGoogle Scholar
• RomanskaHMBerditchevskiFTetraspanins in human epithelial malignanciesJ Pathol2011223141420938929
   PubMedGoogle Scholar
• MalikFASandersAJJiangWGKAI-1/CD82, the molecule and clinical implication in cancer and cancer metastasisHistol Histopathol200924451953019224455
   PubMedGoogle Scholar
• LeeJByunHJLeeMSThe metastasis suppressor CD82/KAI1 inhibits fibronectin adhesion-induced epithelial-to-mesenchymal transition in prostate cancer cells by repressing the associated integrin signalingOncotarget2017811641165427926483
   PubMedGoogle Scholar
• DelaguillaumieAHarriagueJKohannaSTetraspanin CD82 controls the association of cholesterol-dependent microdomains with the actin cytoskeleton in T lymphocytes: relevance to co-stimulationJ Cell Sci2004117Pt 225269528215454569
   PubMedGoogle Scholar
• OdintsovaEVoortmanJGilbertEBerditchevskiFTetraspanin CD82 regulates compartmentalisation and ligand-induced dimerization of EGFRJ Cell Sci2003116Pt 224557456614576349
   PubMedGoogle Scholar
• OdintsovaESugiuraTBerditchevskiFAttenuation of EGF receptor signaling by a metastasis suppressor, the tetraspanin CD82/KAI-1Curr Biol200010161009101210985391
   PubMedGoogle Scholar
• WuQYangYWuSEvaluation of the correlation of KAI1/CD82, CD44, MMP7 and beta-catenin in the prediction of prognosis and metastasis in colorectal carcinomaDiagn Pathol20151017626408312
   PubMedGoogle Scholar
• Pal’TsevaEMSamofalovaOGorbachevaITsar’KovPVExpression of some biomarkers in primary colon adenocarcinomas and their lymph node metastasesArkh Patol20127441218
   PubMedGoogle Scholar
• ProtzelCKakiesCKleistBPoetschMGiebelJDown-regulation of the metastasis suppressor protein KAI1/CD82 correlates with occurrence of metastasis, prognosis and presence of HPV DNA in human penile squamous cell carcinomaVirchows Arch2008452436937518305955
   PubMedGoogle Scholar
• HigashiyamaMKodamaKYokouchiHKAI1/CD82 expression in nonsmall cell lung carcinoma is a novel, favorable prognostic factor: an immunohistochemical analysisCancer-Am Cancer Soc1998833466474
   Google Scholar
• HanZChenZZhengRChengZGongXWangDClinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesisWorld J Surg Oncol2015135625889325
   PubMed Web of Science ®Google Scholar
• ZhangBHLiuWLiLKAI1/CD82 and MRP1/CD9 serve as markers of infiltration, metastasis, and prognosis in laryngeal squamous cell carcinomasAsian Pac J Cancer Prev20131463521352623886139
   PubMedGoogle Scholar
• ZhangBLiuWLiLKAI1/CD82 and cyclin D1 as biomarkers of invasion, metastasis and prognosis of laryngeal squamous cell carcinomaInt J Clin Exp Pathol2013661060106723696923
   PubMedGoogle Scholar
• GuoCLiuQGZhangLSongTYangXExpression and clinical significance of p53, JunB and KAI1/CD82 in human hepatocellular carcinomaHepatobiliary Pancreat Dis Int20098438939619666408
   PubMedGoogle Scholar
• MiyazakiTKatoHKimuraHEvaluation of tumor malignancy in esophageal squamous cell carcinoma using different characteristic factorsAnticancer Res2005256B4005401116309192
   PubMedGoogle Scholar
• FarhadiehRDSmeeROwKDown-regulation of KAI1/CD82 protein expression in oral cancer correlates with reduced disease free survival and overall patient survivalCancer Lett20042131919815312688
   PubMedGoogle Scholar
• GoncharukVNDel-RosarioAKrenLCo-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancerAnn Diagn Pathol20048161615129904
   PubMedGoogle Scholar
• ImaiYSasakiTShinagawaYAkimotoKFujibayashiTExpression of metastasis suppressor gene (KAI1/CD82) in oral squamous cell carcinoma and its clinico-pathological significanceOral Oncol200238655756112167433
   PubMedGoogle Scholar
• SchindlMBirnerPBreiteneckerGOberhuberGDownregulation of KAI1 metastasis suppressor protein is associated with a dismal prognosis in epithelial ovarian cancerGynecol Oncol200183224424811606078
   PubMedGoogle Scholar
• MiyazakiTKatoHShitaraYMutation and expression of the metastasis suppressor gene KAI1 in esophageal squamous cell carcinomaCancer-Am Cancer Soc2000895955962
   Google Scholar
• YangXWeiLTangCSlackRMontgomeryELippmanMKAI1 protein is down-regulated during the progression of human breast cancerClin Cancer Res2000693424342910999724
   PubMedGoogle Scholar
• ShoMAdachiMTakiTTransmembrane 4 superfamily as a prognostic factor in pancreatic cancerInt J Cancer19987955095169761121
   PubMedGoogle Scholar
• HuangCIKohnoNOgawaEAdachiMTakiTMiyakeMCorrelation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patientsAm J Pathol199815339739839736046
   PubMedGoogle Scholar
• AdachiMTakiTIekiYHuangCLHigashiyamaMMiyakeMCorrelation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancerCancer Res1996568175117558620488
   PubMedGoogle Scholar
• SuJSArimaKHasegawaMDecreased expression of KAI1 metastasis suppressor gene is a recurrence predictor in primary pTa and pT1 urothelial bladder carcinomaInt J Urol2004112748214706010
   PubMedGoogle Scholar